GSK Urges Del. Judge To Enhance $235M Skinny Label Win
By Dani Kass · January 28, 2025, 9:27 PM EST
GlaxoSmithKline LLC is urging a Delaware federal judge to enhance the $235 million damages award a jury issued against Teva Pharmaceuticals USA Inc. in 2017, now that the dispute over skinny...
To view the full article, register now.